![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1534405
Àå°ü °ü¸® ½Ã½ºÅÛ ½ÃÀå : ¼¼°è ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м®, ±âȸ, ¿¹Ãø º¸°í¼(2019-2030³â)Bowel Management Systems Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2030, Segmented By Product Type; By Patient Type; By End User; By Indication; By Country |
¼¼°èÀÇ Àå°ü °ü¸® ½Ã½ºÅÛ ½ÃÀå ±Ô¸ð´Â °ÇÀüÇÑ CAGR 4.98%·Î È®´ë, 2030³â±îÁö 32¾ï 4,000¸¸ ´Þ·¯¿¡ µµ´Þ
¼¼°è Àå°ü °ü¸® ½Ã½ºÅÛ ½ÃÀåÀº ¼Òȱâ ÁúȯÀÇ À¯º´·ü Áõ°¡, °í·ÉÈ, ±â¼ú ¹ßÀüÀÇ Ã¤Åà Ȯ´ë, ÀÇ·á ÀÎ½Ä Áõ°¡, ÃÖ¼Ò Ä§½ÀÀû ½Ã¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î ÀÎÇØ ºü¸£°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù.
Àü·« ÄÁ¼³ÆÃ ¹× ½ÃÀå Á¶»ç ±â°üÀÎ BlueWeave ConsultingÀº ÃÖ±Ù Á¶»ç¿¡¼ 2023³â ¼¼°è Àå°ü °ü¸® ½Ã½ºÅÛ ½ÃÀå ±Ô¸ð¸¦ 2024-2030³âÀÇ ¿¹Ãø ±â°£ Áß ±Ý¾× ±âÁØÀ¸·Î 27¾ï 6,000¸¸ ´Þ·¯·Î ÃßÁ¤Çß´Ù, BlueWeave´Â ¼¼°è Àå°ü °ü¸® ½Ã½ºÅÛ ½ÃÀå ±Ô¸ð°¡ ¿¬Æò±Õ 4.98% ¼ºÀåÇÏ¿© 2023³â¿¡´Â 32¾ï 4,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù. ¼¼°è Àå°ü °ü¸® ½Ã½ºÅÛ ½ÃÀåÀÇ ¼ºÀåÀº Àå ÁúȯÀÇ À¯º´·ü Áõ°¡, ³ëÀÎ Àα¸ Áõ°¡, °í±Þ Ä¡·á ¿É¼Ç¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡¿¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ Àå °ü¸® ÀåºñÀÇ ±â¼ú ¹ßÀü, ÀÇ·áºñ ÁöÃâ Áõ°¡, Á¤ºÎ Áö¿øÃ¥ÀÌ ½ÃÀå È®´ë¸¦ ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Áø´Ü ÅøÀÇ °³¼±, ȯÀÚ ¿¹ÈÄ °³¼±, º¯½Ç±Ý ¹ß»ý·ü Áõ°¡ µîÀÇ ¿äÀεµ ½ÃÀå ¼ö¿ä¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. Á¦Ç° Á¢±Ù¼º Çâ»ó, ÃÖ¼Ò Ä§½À ¼ö¼úÀÇ ±ÞÁõ, ȯÀÚÀÇ Æí¾ÈÇÔ¿¡ ´ëÇÑ °ü½É Áõ°¡´Â ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇÒ °ÍÀÔ´Ï´Ù.
±âȸ - °¡Ã³ºÐ ¼Òµæ Áõ°¡
¼¼°è Àå°ü °ü¸® ½Ã½ºÅÛ ½ÃÀåÀº °³¹ßµµ»ó±¹ÀÇ °¡Ã³ºÐ ¼Òµæ Áõ°¡¿¡ ÈûÀÔ¾î Å« ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù. °¡°è ¼ÒµæÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ´õ ¸¹Àº »ç¶÷µéÀÌ °í±Þ Ä¡·á ¹× ÀÇ·á ¼ºñ½º¸¦ ¹ÞÀ» ¼ö ÀÖ°Ô µË´Ï´Ù. ÀÌ·¯ÇÑ °æÁ¦Àû Çâ»óÀ¸·Î ÀÎÇØ Àå°ü °ü¸® ½Ã½ºÅÛ¿¡ ´ëÇÑ Á¢±Ù¼ºÀÌ È®´ëµÇ°í À§Àå Àå¾Ö ȯÀÚÀÇ »îÀÇ ÁúÀÌ Çâ»óµÉ °ÍÀÔ´Ï´Ù. ¶ÇÇÑ ÀÇ·á ÀÎÇÁ¶ó°¡ °ÈµÇ°í Àå °Ç°¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁø °Íµµ ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. À̵é Áö¿ªÀÇ Áß»êÃþ Áõ°¡´Â ¼ö¿ä¸¦ ´õ¿í ÀÚ±ØÇÏ°í ½ÃÀåÀÇ °ß°íÇÑ ¼ºÀå ±Ëµµ¸¦ °ø°íÈ÷ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ÁöÁ¤ÇÐÀû ±äÀå Áõ°¡°¡ ¼¼°è Àå°ü °ü¸® ½Ã½ºÅÛ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâ
ÁöÁ¤ÇÐÀû ±äÀåÀÌ °íÁ¶µÇ¸é °ø±Þ¸Á¿¡ È¥¶õÀ» ÃÊ·¡ÇÏ°í ºñ¿ëÀ» Áõ°¡½ÃÅ´À¸·Î½á ¼¼°è Àå°ü °ü¸® ½Ã½ºÅÛ ½ÃÀå¿¡ Å« ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù. À¯·´°ú ¾Æ½Ã¾ÆÅÂÆò¾ç°ú °°Àº ÁÖ¿ä Áö¿ªÀº Á¦Á¶ ¹× À¯Åë¿¡ ¸Å¿ì Áß¿äÇÏÁö¸¸ ºÒ¾ÈÁ¤ÇÑ »óȲ¿¡ Á÷¸éÇÏ¿© ¿øÀÚÀç ¹× ºÎǰ °ø±ÞÀÌ Áö¿¬µÇ°í °¡°ÝÀÌ ±ÞµîÇϰí ÀÖ½À´Ï´Ù. ·¯½Ã¾Æ¿Í ¿ìÅ©¶óÀ̳ªÀÇ ºÐÀïÀÌ ´ëÇ¥ÀûÀÎ »ç·Ê·Î, Á¦Àç Á¶Ä¡¿Í ¹°·ù ¹®Á¦°¡ ½ÃÀå ¿î¿µÀ» ¹æÇØÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ³ô¾ÆÁö´Â ¹«¿ª À庮°ú ±ÔÁ¦ ºÒÈ®½Ç¼ºÀº ÇコÄÉ¾î ºÐ¾ß ÅõÀÚ¿Í ±â¼ú Çõ½ÅÀ» ÀúÇØÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î ¹Ì±¹°ú Áß±¹ µî ÁÖ¿ä °æÁ¦±¹ °£ÀÇ ¹«¿ªÀüÀïÀº ÇʼöÀûÀÎ ±â¼ú ¹× Àç·á¿¡ ´ëÇÑ Á¢±ÙÀ» Á¦ÇÑÇÏ¿© ½ÃÀå ¼ºÀåÀ» ´õ¿í ¾Ð¹ÚÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀº ÀüüÀûÀ¸·Î Á¦Ç° °³¹ß ¹× ½ÃÀå È®´ë¸¦ µÐȽÃÄÑ ±Ã±ØÀûÀ¸·Î Àü ¼¼°è¿¡¼ Àå°ü °ü¸® ½Ã½ºÅÛÀÇ Á¢±Ù¼º ¹× ±¸¸Å ¿ëÀ̼º¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù.
Àå°ü °ü¸® ½Ã½ºÅÛ ¼¼°è ½ÃÀå
ºÎ¹®º° Àû¿ë ¹üÀ§
Àå°ü °ü¸® ½Ã½ºÅÛ ¼¼°è ½ÃÀå : Á¦Ç° À¯Çüº° ½ÃÀå
Á¦Ç° À¯Çüº°·Î »ìÆìº¸¸é, ¼¼°è Àå°ü °ü¸® ½Ã½ºÅÛ ½ÃÀåÀº °ü°³ ½Ã½ºÅÛ, ÀΰøÇ×¹® ¹é, ½Å°æÁ¶Àý Àåºñ, ¾×¼¼¼¸® ºÎ¹®À¸·Î ³ª´¹´Ï´Ù. ÀΰøÇ×¹®¹é ºÎ¹®Àº ÀΰøÇ×¹® ½Ã¼úÀÌ ÇÊ¿äÇÑ ´ëÀå¾Ï°ú ¿°Áõ¼ºÀåÁúȯÀÇ ³ôÀº À¯º´·ü·Î ÀÎÇØ Á¦Ç° À¯Çüº° ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀΰøÇ×¹®ÀÌ ½ÇÇà °¡´ÉÇÑ °ü¸® ¼Ö·ç¼ÇÀ̶ó´Â Àνİú ¼ö¿ëµµ°¡ ³ô¾ÆÁö¸é¼ ÀΰøÇ×¹®ÀÌ ½ÃÀåÀ» ÁÖµµÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ÆíÀǼº, ȯÀÚÀÇ »îÀÇ Áú Çâ»ó, Àΰø Ç×¹® ¹é ±â¼úÀÇ ¹ßÀüÀº ¼¼°è Àå°ü °ü¸® ½Ã½ºÅÛ ½ÃÀå¿¡¼ÀÇ ¿ìÀ§¸¦ ´õ¿í °ÈÇϰí ÀÖ½À´Ï´Ù.
Àå°ü °ü¸® ½Ã½ºÅÛ ¼¼°è ½ÃÀå-ȯÀÚ À¯Çüº° ½ÃÀå
ȯÀÚ À¯Çüº°·Î ¼¼°è Àå°ü °ü¸® ½Ã½ºÅÛ ½ÃÀåÀº ¼ºÀÎ ºÎ¹®°ú ¼Ò¾Æ ºÎ¹®À¸·Î ³ª´¹´Ï´Ù. ¼ºÀÎ ºÎ¹®ÀÌ ½ÃÀå¿¡¼ °¡Àå Å« ºñÁßÀ» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ÀÌ ºÎ¹®ÀÇ ¿ìÀ§´Â ¼ºÀÎ Àα¸ÀÇ ³ôÀº Àå Áúȯ À¯º´·ü, Àå °ü¸® ¼Ö·ç¼Ç¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, ÀÌ Àα¸ Áý´Ü¿¡¼ ÷´Ü ÀÇ·á ±â¼ú äÅà Ȯ´ë µî¿¡ ±âÀÎÇÕ´Ï´Ù. ¶ÇÇÑ ¿ä½Ç±Ý, ¸¸¼º º¯ºñ µîÀÇ Áõ»óÀ» À¯¹ßÇϱ⠽¬¿î °í·ÉÈ »çȸ´Â ¼ºÀÎ ºÎ¹® ¼ö¿ä¸¦ ´õ¿í Áõ°¡½ÃÄÑ Àüü ½ÃÀå ¼ºÀå°ú ¸ÅÃâ¿¡ °¡Àå Å« ±â¿©¸¦ Çϰí ÀÖ½À´Ï´Ù.
°æÀï ±¸µµ
¼¼°èÀÇ Àå°ü °ü¸® ½Ã½ºÅÛ ½ÃÀåÀº °æÀïÀÌ Ä¡¿ÇÕ´Ï´Ù. ÀÌ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷¿¡´Â Coloplast, Medtronic, Convatec, Hollister Incorporated, B. Braun Melsungen AG, Axonics Inc, Dentsply Sirona, Consure Medical, MBH-International A/S, and Renew Medical Inc. µîÀÌ ÀÖ½À´Ï´Ù. ÀÌµé ±â¾÷Àº ¼¼°è Àå°ü °ü¸® ½Ã½ºÅÛ ½ÃÀå¿¡¼ÀÇ ÀÔÁö¸¦ ´õ¿í °ÈÇϱâ À§ÇØ R&D Ȱµ¿ ÅõÀÚ Áõ°¡, M&A, ÇÕÀÛÅõÀÚ, Á¦ÈÞ, ¶óÀ̼±½º °è¾à, ½ÅÁ¦Ç° ¹× ¼ºñ½º Ãâ½Ã µî ´Ù¾çÇÑ Àü·«À» ±¸»çÇϰí ÀÖ½À´Ï´Ù.
ÀÌ º¸°í¼´Â ¼¼°è Àå°ü °ü¸® ½Ã½ºÅÛ ½ÃÀåÀÇ ¼ºÀå ÀáÀç·Â, ÇâÈÄ µ¿Çâ ¹× Åë°è¿¡ ´ëÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ ÃÑ ½ÃÀå ±Ô¸ð ¿¹ÃøÀ» ÃËÁøÇÏ´Â ¿äÀο¡ ÁÖ¸ñÇϰí ÀÖ½À´Ï´Ù. ÀÌ º¸°í¼´Â ¼¼°è Àå°ü °ü¸® ½Ã½ºÅÛ ½ÃÀåÀÇ Ãֽбâ¼ú µ¿Çâ°ú ÀÇ»ç°áÁ¤ÀÚ°¡ °ÇÀüÇÑ Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ´Â ¾÷°è ÀλçÀÌÆ®À» Á¦°øÇϱâ À§ÇØ ÃÖ¼±À» ´ÙÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, µµÀü °úÁ¦, °æÀï·Â¿¡ ´ëÇØ¼µµ ºÐ¼®ÇÕ´Ï´Ù.
Global Bowel Management Systems Market Size Expands at Healthy CAGR of 4.98% to Touch USD 3.24 Billion by 2030
Global Bowel Management Systems Market is expanding rapidly due to the rising prevalence of gastrointestinal disorders, aging population, growing adoption of technological advancements, increasing healthcare awareness, and growing demand for minimally invasive procedures.
BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the Global Bowel Management Systems Market size by value at USD 2.76 billion in 2023. During the forecast period between 2024 and 2030, BlueWeave expects the Global Bowel Management Systems Market size to expand at a CAGR of 4.98% reaching a value of USD 3.24 billion in 2023. The growth of the Global Bowel Management Systems Market is driven by the increasing prevalence of bowel disorders, the rising geriatric population, and higher awareness about advanced treatment options. Additionally, technological advancements in bowel management devices, growing healthcare expenditures, and supportive government initiatives enhance market expansion. Factors like improved diagnostic tools, better patient outcomes, and the rising incidence of fecal incontinence also contribute to market demand. Enhanced product availability, a surge in minimally invasive procedures, and a heightened focus on patient comfort further stimulate market growth.
Opportunity - Increasing level of disposable incomes
The Global Bowel Management Systems Market is expected to witness significant growth, driven by rising disposable incomes in developing countries. As household incomes increase, more individuals can afford advanced medical treatments and healthcare services. This economic uplift enables greater access to bowel management systems, improving the quality of life for patients with gastrointestinal disorders. Additionally, enhanced healthcare infrastructure and increased awareness of bowel health contribute to the market expansion. The growing middle class in these regions is expected to further stimulate demand, solidifying the market's robust growth trajectory.
Impact of Escalating Geopolitical Tensions on Global Bowel Management Systems Market
Escalating geopolitical tensions can significantly impact the Global Bowel Management Systems Market by disrupting supply chains and increasing costs. Key regions like Europe and Asia Pacific, crucial for manufacturing and distribution, face instability, causing delays and price surges in raw materials and components. The Russia-Ukraine conflict exemplifies this, as sanctions and logistical challenges hinder market operations. Additionally, heightened trade barriers and regulatory uncertainties deter investments and innovations in the healthcare sector. For instance, trade wars between major economies such as the United States and China can lead to restricted access to essential technologies and materials, further straining market growth. These factors collectively slow down product development and market expansion, ultimately affecting the availability and affordability of bowel management systems globally.
Global Bowel Management Systems Market
Segmental Coverage
Global Bowel Management Systems Market - By Product Type
Based on product type, Global Bowel Management Systems Market is divided into Irrigation Systems, Colostomy Bags, Nerve Modulation Devices, and Accessories segments. The colostomy bags segment dominates the market by product type due to the high prevalence of colorectal cancer and inflammatory bowel diseases, which often necessitate colostomy procedures. Additionally, the rising awareness and acceptance of colostomy as a viable management solution contribute to its market leadership. The convenience, improved quality of life for patients, and advancements in colostomy bag technology further bolster their dominance in the Global Bowel Management Systems Market.
Global Bowel Management Systems Market - By Patient Type
By patient type, Global Bowel Management Systems Market is split into Adult and Pediatric segments. The adult segment holds a larger share of the market. The segment's dominance is attributed to the higher prevalence of bowel disorders among the adult population, increasing awareness about bowel management solutions, and the greater adoption of advanced medical technologies in this demographic. Additionally, the aging population, which is more prone to conditions, such as fecal incontinence and chronic constipation, further boosts the demand in the adult segment, making it the largest contributor to the market's overall growth and revenue.
Competitive Landscape
Global Bowel Management Systems Market is fiercely competitive. Major companies in the market include Coloplast, Medtronic, Convatec, Hollister Incorporated, B. Braun Melsungen AG, Axonics Inc, Dentsply Sirona, Consure Medical, MBH-International A/S, and Renew Medical Inc. These companies use various strategies, including increasing investments in their R&D activities, mergers and acquisitions, joint ventures, collaborations, licensing agreements, and new product and service releases to further strengthen their position in the Global Bowel Management Systems Market.
The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of the Global Bowel Management Systems Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Global Bowel Management Systems Market and industry insights to help decision makers make sound strategic decisions. Further, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.
*Financial information of non-listed companies can be provided as per availability.
**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable